This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ybg

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1ybg.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1ybg.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1ybg| PDB=1ybg | SCENE= }}
{{STRUCTURE_1ybg| PDB=1ybg | SCENE= }}
-
'''MurA inhibited by a derivative of 5-sulfonoxy-anthranilic acid'''
+
===MurA inhibited by a derivative of 5-sulfonoxy-anthranilic acid===
-
==Overview==
+
<!--
-
MurA (UDP-N-acetylglucosamine enolpyruvyl transferase, EC 2.5.1.7) catalyzes the first committed step in the synthesis of the bacterial cell wall. It is the target of the naturally occurring, broad-spectrum antibiotic fosfomycin. Fosfomycin, an epoxide, is a relatively poor drug because an ever-increasing number of bacteria have developed resistance to fosfomycin. Thus, there is a critical need for the development of novel drugs that target MurA by a different molecular mode of action. We have identified a new scaffold of potent MurA inhibitors, derivatives of 5-sulfonoxy-anthranilic acid, using high-throughput screening. T6361 and T6362 are competitive inhibitors of MurA with respect to the first substrate, UDP-N-acetylglucosamine (UNAG), with a K(i) of 16 microM. The crystal structure of the MurA.T6361 complex at 2.6 angstrom resolution, together with fluorescence data, revealed that the inhibitor targets a loop, Pro112 to Pro121, that is crucial for the structural changes of the enzyme during catalysis. Thus, this new class of MurA inhibitors is not active site-directed but instead obstructs the transition from the open (unliganded) to the closed (UNAG-liganded) enzyme form. The results provide evidence for the existence of a MurA.UNAG collision complex that may be specifically targeted by small molecules different from ground-state analogs of the enzymatic reaction.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15701635}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15701635 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15701635}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Schonbrunn, E.]]
[[Category: Schonbrunn, E.]]
[[Category: Inside-out alpha-beta barrel]]
[[Category: Inside-out alpha-beta barrel]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 16:06:44 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 16:13:17 2008''

Revision as of 13:13, 28 July 2008

Image:1ybg.png

Template:STRUCTURE 1ybg

MurA inhibited by a derivative of 5-sulfonoxy-anthranilic acid

Template:ABSTRACT PUBMED 15701635

About this Structure

1YBG is a Single protein structure of sequence from Enterobacter cloacae. Full crystallographic information is available from OCA.

Reference

A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA)., Eschenburg S, Priestman MA, Abdul-Latif FA, Delachaume C, Fassy F, Schonbrunn E, J Biol Chem. 2005 Apr 8;280(14):14070-5. Epub 2005 Feb 8. PMID:15701635

Page seeded by OCA on Mon Jul 28 16:13:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1ybg"
Personal tools